Skip to content

Clinical trials

Neoplasm Metastasis trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Country / region: Germany Clear all

301 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20028
20037
20047
20057
20066
20079
20089
200914
20109
201111
201214
201314
201415
201512
201614
201712
20188
201912
202017
202122
202217
20238
202410
202515
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed140
Terminated53
Recruiting43
Active, not recruiting36
Unknown status21
Withdrawn4
Not yet recruiting3
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company21
AstraZeneca20
Novartis Pharmaceuticals19
Sanofi10
Bayer8
Pfizer8
AIO-Studien-gGmbH7
European Organisation for Research and Treatment of Cancer - EORTC7
iOMEDICO AG7
AbbVie6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis301
Neoplasms60
Breast Neoplasms51
Colorectal Neoplasms40
Carcinoma, Non-Small-Cell Lung37
Melanoma23
Prostatic Neoplasms17
Pancreatic Neoplasms16
Recurrence16
Colonic Neoplasms15

Trials

Showing 1 to 25 of 301. Each trial links to its page on Pharma Observatory.

201 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.